Novel inflammation biomarkers in adult minimal change disease: predicting steroid-resistance and relapse
The novel systemic inflammation markers CAR and dNLR may play significant roles in steroid treatment and the prognosis of MCD in adults, and deeper clinical studies in the future are warranted.
Authors
- Xiangcheng Xiao (ORCID: https://orcid.org/0000-0003-2515-5503)
- Huipeng Ge
- Zhangzhe Peng (ORCID: https://orcid.org/0009-0002-0804-3921)
- Qiongjing Yuan
- Wenbin Tang (ORCID: https://orcid.org/0000-0002-3062-5963)
- Weiwei Zhang (ORCID: https://orcid.org/0000-0003-0888-0447)
- Wei Lin (ORCID: https://orcid.org/0000-0002-7506-3466)
Institutions
- Central South University (CN)
- Collaborative Research Group (AU)
- National Clinical Research (US)
- Xiangya Hospital Central South University (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1186/s40001-025-03279-8
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China